Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Neoplasm Metastasis 1

Interventions

Radiosurgery 7 Oxaliplatin 7 Docetaxel 7 Paclitaxel 5 Fluorouracil 5 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Gemcitabine 4 Carboplatin 4 Capecitabine 4 Trastuzumab 3 Radiotherapy 3 Radiation 3 Leucovorin 3 Erlotinib Hydrochloride 3 Cyclophosphamide 3 Cetuximab 3 Bevacizumab 3 spartalizumab 2 sipuleucel-T 2 repotrectinib 2 pembrolizumab 2 pazopanib 2 orteronel 2 fludarabine 2 atezolizumab 2 aldesleukin 2 Temozolomide 2 Surveys and Questionnaires 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neoplasm Metastasis × cediranib × Clear all

NCT04184518 2020-06-02

CEDUVEAL-M

Grupo Español Multidisciplinar de Melanoma

Phase 2 Withdrawn

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡